Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostatic Neoplasms × semaglutide × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Zoledronic Acid 9 Leuprolide 8 luprolide acetate gel depot 5 enzalutamide 5 bicalutamide 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Triptorelin Pamoate 4 Dutasteride 4 darolutamide 3 Magnetic Resonance Spectroscopy 3 Goserelin 3 Flutamide 3 Androgen Antagonists 3 Abiraterone Acetate 3 fluciclovine F-18 2 Sodium Chloride 2 Propofol 2 Prednisone 2 Prednisolone 2 Gonadotropin-Releasing Hormone 2 Finasteride 2 Dexamethasone 2 Desflurane 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 testosterone 17 beta-cypionate 1 semaglutide 1 polyethylene glycol 3350 1 pegylated granulocyte colony-stimulating factor, human 1 pasireotide 1 gadoteridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06908694 2025-07-29

GAINPCCONTROL

Hamilton Health Sciences Corporation

Phase 4 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡